Chart Industries reported a decrease in overall orders due to large LNG project orders in the prior year, but saw increased demand in medical oxygen products due to COVID-19. The company executed on cost savings and achieved higher gross margins. They are withdrawing full year guidance due to COVID-19 uncertainty.
Orders for medical oxygen critical care products increased by 34% over Q1 2019.
Gross margin as a percent of sales increased to 28.5%, up 530 basis points from Q1 2019.
Executed $49 million of annualized cost savings year-to-date 2020.
Adjusted earnings per diluted share was $0.57, a 46% increase over Q1 2019.
Chart Industries withdrew its prior 2020 full-year guidance due to uncertainty related to COVID-19, but provided data points including Venture Global's Calcasieu Pass project revenue expectations, short-term increase in demand in medical related products, and continued prioritization of debt paydown.